Khalid Al Sulaiman

810 total citations
72 papers, 350 citations indexed

About

Khalid Al Sulaiman is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Khalid Al Sulaiman has authored 72 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 19 papers in Epidemiology and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Khalid Al Sulaiman's work include COVID-19 Clinical Research Studies (18 papers), Sepsis Diagnosis and Treatment (11 papers) and Long-Term Effects of COVID-19 (10 papers). Khalid Al Sulaiman is often cited by papers focused on COVID-19 Clinical Research Studies (18 papers), Sepsis Diagnosis and Treatment (11 papers) and Long-Term Effects of COVID-19 (10 papers). Khalid Al Sulaiman collaborates with scholars based in Saudi Arabia, United States and Belgium. Khalid Al Sulaiman's co-authors include Ohoud Aljuhani, Ramesh Vishwakarma, Shmeylan Al Harbi, Aisha Alharbi, Hisham A. Badreldin, Ghazwa B. Korayem, Khalid Eljaaly, Sharon L. Forbes, Abdullah Alhammad and Khalid Bin Saleh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Critical Care Medicine.

In The Last Decade

Khalid Al Sulaiman

57 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Khalid Al Sulaiman Saudi Arabia	10	118	70	69	67	38	72	350
Dipu T Sathyapalan India	10	65 0.6×	50 0.7×	31 0.4×	73 1.1×	34 0.9×	43	315
Merlin Moni India	9	56 0.5×	48 0.7×	32 0.5×	69 1.0×	34 0.9×	37	269
Farhad Najmeddin Iran	11	122 1.0×	25 0.4×	58 0.8×	88 1.3×	33 0.9×	45	363
Bikha Ram Devrajani Pakistan	11	69 0.6×	58 0.8×	25 0.4×	80 1.2×	23 0.6×	40	523
Mir Mohammad Miri Iran	12	123 1.0×	36 0.5×	59 0.9×	74 1.1×	46 1.2×	53	403
Mojtaba Shafiekhani Iran	10	117 1.0×	31 0.4×	29 0.4×	46 0.7×	17 0.4×	51	336
Deepali Dixit United States	12	40 0.3×	24 0.3×	56 0.8×	62 0.9×	93 2.4×	41	467
Fahad Gul United States	12	364 3.1×	84 1.2×	173 2.5×	75 1.1×	65 1.7×	19	650
Michael F. Canarie United States	10	59 0.5×	61 0.9×	13 0.2×	97 1.4×	30 0.8×	16	451
Anees Sindi Saudi Arabia	9	65 0.6×	98 1.4×	74 1.1×	161 2.4×	175 4.6×	21	528

Countries citing papers authored by Khalid Al Sulaiman

Since Specialization

Citations

This map shows the geographic impact of Khalid Al Sulaiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Al Sulaiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Al Sulaiman more than expected).

Fields of papers citing papers by Khalid Al Sulaiman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid Al Sulaiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Al Sulaiman. The network helps show where Khalid Al Sulaiman may publish in the future.

Co-authorship network of co-authors of Khalid Al Sulaiman

This figure shows the co-authorship network connecting the top 25 collaborators of Khalid Al Sulaiman. A scholar is included among the top collaborators of Khalid Al Sulaiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalid Al Sulaiman. Khalid Al Sulaiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thabit, Abrar K., Khalid Al Sulaiman, Shuroug A. Alowais, et al.. (2025). Nitrofurantoin Versus Comparators in the Treatment of Cystitis due to Extended-Spectrum β-Lactamase–Producing Enterobacterales: A Multicenter Cohort Study. Annals of Pharmacotherapy. 59(9). 785–793.

Alharthi, Abdullah F., et al.. (2025). Managing Infections in Burn Patients: Strategies and Considerations for Antimicrobial Dosing. PubMed. 6(4). 53–53.

Sulaiman, Khalid Al, et al.. (2024). Opioid and benzodiazepine requirements in critically ill post-surgical children with down syndrome: a systematic review and meta-analysis. BMC Pediatrics. 24(1). 504–504.

Sulaiman, Khalid Al, et al.. (2024). The concomitant use of ultra short beta-blockers with vasopressors and inotropes in critically ill patients with septic shock: A systematic review and meta-analysis of randomized controlled trials. Saudi Pharmaceutical Journal. 32(6). 102094–102094.

Sulaiman, Khalid Al, Ohoud Aljuhani, Hadeel Alkofide, et al.. (2024). Evaluation of Apixaban standard dosing in underweight patients with non-valvular atrial fibrillation: a retrospective cohort study. Thrombosis Journal. 22(1). 43–43. 1 indexed citations

Aljuhani, Ohoud, Khalid Al Sulaiman, Ghazwa B. Korayem, et al.. (2024). The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study. Scientific Reports. 14(1). 3037–3037. 4 indexed citations

Alatawi, Yasser, et al.. (2024). Insights into risk factors and outcomes of post-stroke seizures in Saudi Arabia: a multicenter analysis. Metabolic Brain Disease. 40(1). 72–72. 4 indexed citations

Aljuhani, Ohoud, et al.. (2024). Evaluating the effectiveness of nicotine replacement therapy in critically ill smokers: A meta-analysis of randomized controlled trials. Tobacco Induced Diseases. 22(August). 1–10. 2 indexed citations

Aljuhani, Ohoud, Khalid Al Sulaiman, Ghazwa B. Korayem, et al.. (2024). Ketamine-based Sedation Use in Mechanically Ventilated Critically Ill Patients with COVID-19: A Multicenter Cohort Study. Saudi Pharmaceutical Journal. 32(5). 102061–102061. 1 indexed citations

10.

Aljuhani, Ohoud, Ghazwa B. Korayem, Ali F. Altebainawi, et al.. (2023). The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study. Saudi Pharmaceutical Journal. 31(7). 1210–1218. 1 indexed citations

11.

Badreldin, Hisham A., et al.. (2022). What the near Future Holds for Sacubitril/Valsartan: A Summary of Major Ongoing Studies. Journal of Cardiovascular Development and Disease. 9(2). 54–54. 5 indexed citations

12.

Badreldin, Hisham A., Khalid Bin Saleh, Abdullah A. Alhifany, et al.. (2022). Assessing the Perception of Pharmacy Students on Launching a Doctor of Pharmacy/Master of Public Health Dual Degree Program in Saudi Arabia: A Multi-Institutional Cross-Sectional Study. International Journal of Environmental Research and Public Health. 19(13). 8014–8014.

13.

Sulaiman, Khalid Al, et al.. (2022). The correlation between non-O blood group type and recurrent catheter-associated urinary tract infections in critically ill patients: A retrospective study. Journal of International Medical Research. 50(7). 3629169010–3629169010. 4 indexed citations

14.

Sulaiman, Khalid Al, et al.. (2022). Apixaban Use in Patients with Protein C and S Deficiency: A Case Series and Review of Literature. SHILAP Revista de lepidopterología. 3 indexed citations

15.

Sulaiman, Khalid Al, et al.. (2022). Impact of Ursodeoxycholic Acid in Critically Ill Patients With Sepsis: A Retrospective Study. Journal of Pharmacy Practice. 36(3). 566–571. 1 indexed citations

16.

Sulaiman, Khalid Al, et al.. (2021). Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study. Clinical and Applied Thrombosis/Hemostasis. 27. 2975232427–2975232427. 5 indexed citations

17.

Sulaiman, Khalid Al, Ohoud Aljuhani, Khalid Eljaaly, et al.. (2021). Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study. International Journal of Infectious Diseases. 105. 180–187. 34 indexed citations

18.

Saleh, Khalid Bin, Khalid Al Sulaiman, Ohoud Aljuhani, et al.. (2021). Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with coronavirus disease 2019 (COVID-19): A multicenter cohort study. SHILAP Revista de lepidopterología. 7. 100033–100033. 4 indexed citations

19.

Sulaiman, Khalid Al, Abdulrahman Alshaya, Ohoud Aljuhani, et al.. (2021). The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study. BMC Infectious Diseases. 21(1). 1182–1182. 5 indexed citations

20.

Alqahtani, Saeed M., et al.. (2015). Control of type 2 diabetes in King Abdulaziz Housing City (Iskan) population, Saudi Arabia. Journal of Family and Community Medicine. 23(1). 1–1. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact